A possible role of histone-like DNA-binding protein of Streptococcus intermedius in the pathogenesis of bile duct damage in primary biliary cirrhosis

Clinical Immunology

Volumn 127, Issue 2, 2008, Pages 245-251

  Haruta, Ikuko ^a   Kikuchi, Ken ^b   Hashimoto, Etsuko ^a   Kato, Hidehito ^a   Hirota, Katsuhiko ^c   Kobayashi, Makio ^a   Miyake, Yoichiro ^c   Uchiyama, Takehiko ^a   Yagi, Junji ^a   Shiratori, Keiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Gram positive bacteria; Histone like DNA binding protein (HLP); Lipoteichoic acid (LTA); Primary biliary cirrhosis (PBC); Streptococcus intermedius

Indexed keywords

DNA BINDING PROTEIN; IMMUNOGLOBULIN M ANTIBODY; STREPTOCOCCUS ANTIGEN;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BACTERIAL CELL; BACTERIUM IDENTIFICATION; BILE DUCT INJURY; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; INFLAMMATORY CELL; LIVER HILUS; MALE; PATHOGENESIS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; STREPTOCOCCUS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS INTERMEDIUS;

ADULT; AGED; ANTIBODIES, BACTERIAL; BIOPSY; DNA-BINDING PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS INTERMEDIUS;

EID: 41549133879     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.01.010     Document Type: Article

References (39)

1. Kaplan M.M. Primary biliary cirrhosis. New Engl. J. Med. 335 (1996) 1570-1580
2. Nishio A., Keeffe E.B., and Gershwin M.E. Immunopathogenesis of primary biliary cirrhosis. Semin. Liver Dis. 22 3 (2002) 291-302
3. Shimoda S., Nakanuma M., Ishibashi H., Hayashida K., and Niho Y. HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune disease. J. Exp. Med. 181 (1995) 1835-1845
4. Fussey S.P., Ali S.T., Guest J.R., James O.F., Bassendine M.F., and Yeaman S.J. Reactivity of primary biliary cirrhosis with Escherichia coli dihydrolipoamide acetyltransferase (E2p): characterization of the main immunogenic region. Proc. Natl. Acad. Sci. 87 10 (1990) 3987-3991
5. Selmi C., Balkwill D.L., Invernizzi P., Ansari A.A., Coppel R.L., Podda M., et al. Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology 38 5 (2003) 1250-1257
6. Kaplan M.M. Novosphingobium aromaticivorans: a potential initiator of primary biliary cirrhosis. Am. J. Gastroenterol. 99 (2004) 2147-2149
7. Hiramatsu K., Harada K., Tsuneyama K., Sasaki M., Fujita S., Hashimoto T., et al. Amplification and sequence analysis of partial bacterial 16S ribosomal RNA gene in gallbladder bile from patients with primary biliary cirrhosis. J. Hepatol. 33 1 (Jul 2000) 9-18
8. Harada K., Tsuneyama K., Sudo Y., Masuda S., and Nakanuma Y. Molecular identification of bacterial 16S ribosomal RNA gene in liver tissue of primary biliary cirrhosis: is propionibacterium acnes involved in granuloma formation?. Hepatology 33 (2001) 530-536
9. Haruta I., Hashimoto E., Kato Y., Kikuchi K., Kato H., Yagi J., et al. Lipoteichoic acid may affect the pathogenesis of bile duct damage in primary biliary cirrhosis. Autoimmunity 39 2 (2006) 129-135
10. Keller R., Fischer W., Keist R., and Basseti S. Macrophage response to bacteria: induction of marked secretory and cellular activity by lipoteichoic acids. Infect. Immun. 60 (1992) 3664-3672
11. Henneke P., Morath S., Uematsu S., Weichert S., Pfitzenmaier M., Takeuchi O., et al. Role of lipoteichoic acid in the phagocyte response to group B streptococcus. J. Immunol. 174 (2005) 6449-6455
12. -/-mice. Hepatol. Res. 34 (2006) 3-8
13. -/- mice. Autoimmunity 40 5 (2007) 372-379
14. -/- mice: does lipoteichoic acid affect the pathogenesis of epithelial inflammation followed by fibrosis?. Ann. N. Y. Acad. Sci. 1107 (2007) 300-307
15. Murakami K., Hirota K., Nemoto K., Ono T., Matsuo T., and Miyake Y. Pathogenicity of an oral bacterium Streptococcus intermedius in liver disease. J. Dent. Res. 77 (1998) 728
16. Liu D., Yumoto H., Hirota K., Murakami K., Takahashi K., Hirao K., et al. Histone-like DNA binding protein of Streptococcus intermedius induces the expression of pro-inflammatory cytokines in human monocytes via activation of ERK1/2 and JNK pathways. Cellular Microbiology 10 1 (2008) 267-276 (Electronic publication ahead of print 2007 Sep 20)
17. Whiley R.A., Fraser H., Hardie J.M., and Beighton D. Phenotypic differentiation of Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus strains within the "Streptococcus milleri group". J. Clin. Microbiol. 28 (1990) 1497-1501
18. Clarridge III J.E., Osting C., Jalali M., Osborne J., and Wannington M. Genotypic and phenotypic characterization of "Streptococcus milleri" group isolates from a veterans administration hospital population. J. Clin. Microbiol. 31 11 (1999) 3681-3687
19. Whiley R.A., Beighton D., Winstanley T.G., Fraser H.Y., and Hardie J.M. Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (the Streptococcus milleri group): association with different body sites and clinical infections. J. Clin. Microbiol. 30 1 (1992) 243-244
20. Stinson M.W., Mclaughlin R., Choi S.H., et al. Streptococcal histone-like protein: primary structure of hlpA and protein binding to lipoteichoic acid and epithelial cells. Infect. Immun. 61 1 (1998) 259-265
21. Broyles S., and Pettijohn D. Interaction pf the Escherichia coli HU protein with DNA. Evidence for formation of nucleosome-like structures with altered helical pitch. J Mol. Biol. 187 (1986) 47-60
22. Rouviere-Yaniv J., Germond J., and Yaniv M. E. coli DNA binding protein HU forms nucleosome-like structures with circular double-stranded DNA. Cell 117 (1979) 265-274
23. Petersen F.C., Pecharki D., and Scheie A.A. Biofilm mode of growth of Streptococcus intermedius favored by a competence-stimulating signal peptide. J. Bacteriol. 186 18 (2004) 6327-6331
24. Fischer W. Physiology of lipoteichoic acid in bacteria. Adv. Microb. Physiol. 29 (1988) 233-302
25. Chou M.J., Lee S.L., Chen T.Y., and Tsay G.J. Specificity of antinuclear antibodies in primary biliary cirrhosis. Ann. Rheum. Dis. 54 (1995) 148-151
26. Portmann B.C., and Nakanuma Y. Diseases of the bile ducts. In: MacSween R.N.M., Burt A.D., Portmann B.C., et al. (Eds). Pathology of the Liver (2002), Churchill Livingstone, London 442
27. Desmet V.J., Gerber M., Hoofnagle J.H., Manns M., and Scheuer P.J. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19 (1994) 1513-1520
28. X oligosaccharide and common causative oral bacteria of infective endocarditis. FEMS Immunol. Med. Microbiol. 12 (1995) 159-164
29. Hughes R. Campylobacter jejuni in Guillain-Barre syndrome. Lancet Neurol. 3 11 (2004) 644
30. Tsang R.S. The relationship of Campylobacter jejuni infection and the development of Guillain-Barre syndrome. Curr. Opin. Infect. Dis. 15 3 (2002) 221-228
31. Franchini M., and Veneri D. Helicobacter pylori infection and immune thrombocytopenic purpura: an update. Helicobacter 9 4 (2004) 342-346
32. Oldstone M.B.A. Molecular mimicry and immune-mediated disease. FASEB J. 12 (1998) 1255-1265
33. Jones D.F., Palmer J.M., Burt A.D., Walker C., Robe A.J., and Kirby J.A. Bacterial motif DNA as an adjuvant for the breakdown of immune self-tolerance to pyruvate dehydrogenase complex. Hepatology 36 (2002) 679-686
34. In: Brooks G.F., Butel J.S., and Morse S.A. (Eds). Jawetz, Melnick and Adelberg's Medical Microbiology (1998), Prentice Hall International, Inc., Stamford, CT 203-217
35. In: Murray P.R., Rosenthal K.S., Kobayashi G.S., and Pfaller M.A. (Eds). Medical Biology (2002), Mosby, Inc., A Harcourt Health Science Company, London 217-235
36. Wakabayashi K., Lian Z.X., Morotoki Y., Lan R.Y., Tsuneyama K., Chuang Y.H., et al. IL-2 receptor alpha(-/-) mice and the development of primary biliary cirrhosis. Hepatology 44 5 (2006) 1240-1249
37. Oertelt S., Lian Z.X., Cheng C.M., Chuang Y.H., Padgett K.A., He X.S., et al. Anti-mitochondrial antibodies and primary biliary cirrhosis: TGF-beta receptor II dominant-negative mice. J. Immunol. 177 3 (2006) 1655-1660
38. Irie J., Wu Y., Wicker L.S., Rainbow D., Nalesnik M.A., Hirsch R., et al. NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis. J. Exp. Med. 203 5 (2006) 1209-1219
39. Yuki N. carbohydrate mimicry: a new paradigm of autoimmune disease. Curr. Opin. Immunol. 17 (2005) 577-582